An Instagram reel in October 2026 said a supermarket mushroom boiled in water makes tumours vanish. The mushroom is enoki, and the research behind the claim is real. It just does not say that.
What the old studies found
Enoki (Flammulina velutipes) was among the first mushrooms studied for cancer. In 1985 a Japanese team isolated a glycoprotein called proflamin from the fungus’s culture mycelium. Given by mouth at 10 mg/kg, it raised median survival by 86% in mice with B-16 melanoma and by 84% in mice with adenocarcinoma 755. Yet proflamin showed no cell-killing effect on cultured cell lines. The researchers read that as an immune effect, not direct tumour destruction.
A Korean study extracted enoki fruit bodies in hot water and purified a protein-bound polysaccharide fraction. At 10 mg/kg a day for ten days it inhibited sarcoma 180 growth in mice by 62.3%, and the tumours regressed completely in three of the ten mice. A 1983 Japanese paper on another polysaccharide, EA6, found it prolonged survival of leukemia-challenged mice by 223%, but only when given at the right dose, after a vaccine.
A 2009 study in the journal Immunology tested an enoki protein, Fve, alongside an HPV antigen. Of mice immunised with both, 60% stayed tumour-free for up to 167 days after challenge, against 20% of those given the antigen alone.
The Nagano numbers
The human angle comes from Dr. Tetsuro Ikekawa, an epidemiologist at the National Cancer Center in Tokyo. He noticed that cancer rates in Nagano Prefecture, Japan’s centre of enoki cultivation, were unusually low between 1972 and 1986. Growers often gave staff the bruised mushrooms that would not sell, so growers’ families ate far more enoki than their neighbours.
The prefecture’s cancer death rate was 160 per 100,000. Among enoki growers’ families it was 97. Deaths fell 36.6% for men and 42.7% for women in a population of around 175,000, age-adjusted. It is a striking gap, but it is a comparison of groups, not a trial. Nothing in it separates mushrooms from other diet or lifestyle differences.
Why the reel overreaches
The mouse results used purified proteins and polysaccharides, mostly by injection or measured oral dose, not a pot of boiled mushrooms. Test-tube work points the same way: a 2013 study found enoki extract may have blocked liver cancer cells, a 2012 study reported compounds that suppressed stomach cancer cells by up to 95%, and a 2015 study saw eight medicinal mushroom extracts slow breast and cervical cancer cells. The catch, as Healthline’s review notes, is that those studies used highly concentrated extracts, far beyond a normal serving.
Enoki is a nutritious food, with fibre, B vitamins (especially niacin) and antioxidants. A 2014 hamster study linked enoki powder to lower triglycerides and LDL cholesterol. No study here shows that eating or boiling enoki shrinks a tumour. Anyone changing their diet during cancer treatment should talk to their oncologist first.
Sources
- Proflamin, a new antitumor agent: preparation, physicochemical properties and antitumor activity.
- Intensification of antitumor-immunity by protein-bound polysaccharide, EA6, derived from Flammulina velutipes (Curt. ex Fr.) Sing. combined with murine leukemia L1210 vaccine in animal experiments.
- Studies on Antitumor Components of Flammulina velutipes of Korea(I) -Antitumor Activity against Sarcoma 180-
- Can Eating Enoki Mushrooms Lower Your Cancer Risk?
- 7 Unique Benefits of Enoki Mushrooms
Photo: Fumikas Sagisavas (CC0)





